A detailed history of Hendershot Investments Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hendershot Investments Inc. holds 3,131 shares of NVS stock, worth $365,231. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,131
Previous 3,131 -0.0%
Holding current value
$365,231
Previous $302,000 10.26%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$95.27 - $108.47 $7,145 - $8,135
-75 Reduced 2.34%
3,131 $302,000
Q1 2023

Apr 25, 2023

SELL
$80.03 - $92.81 $36,013 - $41,764
-450 Reduced 12.31%
3,206 $294,000
Q4 2022

Jan 24, 2023

SELL
$75.55 - $92.52 $9,443 - $11,565
-125 Reduced 3.31%
3,656 $0
Q2 2022

Jul 22, 2022

SELL
$80.52 - $93.75 $3,703 - $4,312
-46 Reduced 1.2%
3,781 $320,000
Q4 2021

Feb 04, 2022

BUY
$79.7 - $88.13 $305,011 - $337,273
3,827 New
3,827 $335,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $251B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hendershot Investments Inc. Portfolio

Follow Hendershot Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendershot Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hendershot Investments Inc. with notifications on news.